P53 could be key to therapies for salivary gland cancer



P53 could be key to therapies for salivary gland cancer

Researchers found that certain drugs can change the fundamental makeup of cancer stem cells in mouse models of mucoepidermoid carcinoma — a lethal form of salivary gland cancer that currently has no treatment options.

Materials provided by Michigan Medicine – University of Michigan. Original written by Anna Megdell. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

1st June 2023

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Read more
31st May 2023

Plants remove cancer causing toxins from air

Read more
31st May 2023

How the flu virus hacks our cells

Read more